how to approach r/r cll
Published 2 years ago • 136 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
2:34
sequencing of therapies in patients with r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
5:30
targeting ror1 and a two-drug approach to cure cll
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
6:34
raytrace premium iol calculator tutorial
-
5:17
living with cll - michael's story
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
2:36
treatment approaches to cll with high-risk molecular features
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
2:41
r/r cll: combination therapy and tailored treatment
-
2:35
the role of mrd in clinical decision-making in r/r cll
-
1:29
nvg-111, a ror1 targeting bispecific tce, in r/r cll and mcl: a proof of concept phase i study
-
1:38
therapeutically targeting transcription factors in cll
-
1:00
epcoritamab monotherapy and combinations in r/r cll and richter’s syndrome
-
1:31
novel approaches to cll treatment
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll